Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3995 (99th)

Pharmaceutical Export Amendments of 1986

openUnited States· United States Congress· EN

Introduced

19 December 1985

Last action

28 April 1986 · Committee

Status

Subcommittee Hearings Held.

Sponsors

Rep. Madigan, Edward R. [R-IL-15], Rep. Scheuer, James H. [D-NY-8], Rep. Broyhill, James T. [R-NC-10], Rep. Sharp, Philip R. [D-IN-2], Rep. Lent, Norman F. [R-NY-4], Rep. Luken, Thomas A. [D-OH-1], Rep. Nielson, Howard C. [R-UT-3], Rep. Tauke, Thomas Joseph [R-IA-2], Sen. Shelby, Richard C. [R-AL], Rep. Ritter, Don [R-PA-15], Rep. Bliley, Tom [R-VA-7], Rep. Tauzin, W. J. (Billy) [R-LA-3], Rep. Whittaker, Bob [R-KS-5], Rep. Dowdy, Wayne [D-MS-4], Rep. Dannemeyer, William E. [R-CA-39], Rep. Bilirakis, Michael [R-FL-9], Rep. Gallo, Dean A. [R-NJ-11], Rep. Dwyer, Bernard J. [D-NJ-6], Rep. Hall, Ralph M. [R-TX-4], Rep. Oxley, Michael G. [R-OH-4], Rep. Eckart, Dennis E. [D-OH-11], Rep. McEwen, Bob [R-OH-6], Rep. Smith, Lawrence [D-FL-16], Rep. Bereuter, Doug [R-NE-1], Rep. Boehlert, Sherwood [R-NY-24], Rep. Rangel, Charles B. [D-NY-15], Rep. Kindness, Thomas N. [R-OH-8], Rep. Regula, Ralph [R-OH-16], Rep. Price, Melvin [D-IL-21], Rep. Whitehurst, G. William [R-VA-2], Rep. Robinson, Tommy F. [D-AR-2], Rep. Wortley, George C. [R-NY-27], Sen. Coats, Daniel [R-IN], Rep. Fazio, Vic [D-CA-3], Rep. Lagomarsino, Robert J. [R-CA-19], Rep. Towns, Edolphus [D-NY-10], Sen. Jeffords, James M. [I-VT], Rep. Dornan, Robert K. [R-CA-46], Rep. Lightfoot, Jim [R-IA-3], Rep. Strang, Michael L. [R-CO-3], Rep. Smith, Neal Edward [D-IA-4], Rep. Martin, Lynn M. [R-IL-16], Rep. McDade, Joseph M. [R-PA-10], Rep. Chandler, Rod D. [R-WA-8], Rep. Bonior, David E. [D-MI-10], Rep. Beilenson, Anthony C. [D-CA-24], Rep. Bartlett, Steve [R-TX-3], Rep. Cobey, William W. [R-NC-4]

Subjects

Discovery layer

Source updated

3 June 2026

Official sourceView documentsShare

Summary

Pharmaceutical Export Amendments of 1986 - Amends the Federal Food, Drug, and Cosmetic Act to permit the export of certain drugs (including biological products) intended for human or animal use even though such drugs have not been approved or licensed for use in the United States. Directs the Secretary of Health and Human Services to establish and update a two-tiered list of countries with adequate governmental health authorities which in the first tier includes developed regulatory procedures and tests with experienced scientific personnel and in the second tier includes sufficient ability to assure consistency of labeling information. Permits shipments to nonlist countries if differing health conditions there make such shipments desirable, e. g. tropical diseases. Permits the export of an unapproved drug to a second tier country if such drug is approved for use in any first-tier country and not banned for use in any first-tier country. Prohibits the export of drugs denied approval on the basis of safety and efficacy or whose manufacture in the United States has been determined to be contrary to U.S. health and safety. Sets forth other criteria and restrictions on the export of such drugs, including notice requirements on shipments and notice of and opportunity to cure deficiencies in such shipments. Permits the Secretaries of Agriculture and Health and Human Services to prohibit noncomplying shipments and shipments otherwise permitted if either Secretary determines a shipment would present an imminent hazard to the public health of the recipient country. Requires the Comptroller General to report biennially to the Secretary of Health and Human Services and the Congress on the extent to which drugs unauthorized for a country are being received by such country and the extent to which labeling is consistent. Directs the Secretary to contract for a study to be submitted to the Congress within five years on the economic and international health impact of this Act. Includes conditions prevalent in a developing country among the criteria for orphan drugs.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 19 December 1985

    Introduced

    Referred to House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 19 December 1985

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 19 December 1985

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 20 December 1985

    Referred

    Referred to Subcommittee on Health and the Environment.

    Source: Committee

  5. 28 April 1986

    Committee

    Subcommittee Hearings Held.

    Source: Committee

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 76 sponsors and actors.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.